Chronic Pain Clinical Trial
— SoV-studienOfficial title:
Internet Administered CBT for Insomnia Comorbid With Chronic Pain Compared to Applied Relaxation Techniques - A Randomized Controlled Trial
| NCT number | NCT03425942 |
| Other study ID # | LIU-002 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | February 9, 2018 |
| Est. completion date | May 14, 2019 |
| Verified date | January 2021 |
| Source | Linkoeping University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Cognitive behavioural therapy (CBT), that is designed to be short, concise and user friendly is compared to applied relaxation techniques as treatment for insomnia comorbid with chronic pain. Both treatments are administered via internet and participants are randomized to ether treatment arm.
| Status | Completed |
| Enrollment | 54 |
| Est. completion date | May 14, 2019 |
| Est. primary completion date | May 7, 2019 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 65 Years |
| Eligibility | Inclusion Criteria: - Insomnia severity index (ISI) score > 14 - Chronic pain Exclusion Criteria: - Shift worker or employed as a driver, operator of dangerous equipment and such - Sleep apnea, restless legs syndrome, narcolepsy, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - Bipolar disorder, psychotic disorders, ongoing substance abuse - Having received CBT for insomnia during the latest year - Pregnancy - Severe somatic disorder (such as ongoing cancer, severe neurological condition, insufficiently treated cardiac condition) - Impaired movement to such a degree that going to bed or getting out of bed requires assistance - Not being able read or wright in Swedish - Not having an internet-connected computer, cellular phone or tablet |
| Country | Name | City | State |
|---|---|---|---|
| Sweden | Rehabilitation medicine, IMH, Linköping University | Linköping | Östergötland |
| Lead Sponsor | Collaborator |
|---|---|
| Linkoeping University |
Sweden,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Pain spreading (PS) | Number of anatomical regions with pain out of 36 anatomical areas. | Change from baseline pain spreading (PS) at 6 months | |
| Other | Negative Effects Questionnaire (NEQ) | Monitoring and Reporting Adverse and Unwanted Events (32 items). Range 0-128 where a higher value indicates more adverse events. | at 5 weeks and at 6 months | |
| Other | Patient Health Questionnaire (PHQ-4) | Measures depressive symptoms and anxiety. Range 0-12 where a higher value indicates more depressive or anxiety symptoms. | Change from baseline health (PHQ-4) at 5 weeks | |
| Primary | Insomnia Severity Index (ISI) | Measures degree of insomnia. Range 0-28 where a higher value indicates worse sleep. | Change from baseline insomnia severity (ISI) at 6 months | |
| Secondary | Sleep diary | Basis for sleep latency, total sleep time, wake time after sleep onset and sleep efficiency. | Daily during treatment (five weeks). | |
| Secondary | The Karolinska Sleepiness Scale (KSS) | Measures sleepiness on a single item numeric rating scale. Range 1-9, where a higher value indicates more sleepiness. | Change from baseline sleepiness (KSS) at 5 weeks | |
| Secondary | Patient Health Questionnaire (PHQ-9) | Measures depressive symptoms. Range 0-27, where a higher value indicates more depressive symptoms. | Change from baseline health (PHQ-9) at 6 months | |
| Secondary | Generalised Anxiety Disorder 7-item scale (GAD-7) | Measures anxiety symptoms. Range 0-21 where a higher value indicates more anxiety. | Change from baseline anxiety (GAD-7) at 6 months | |
| Secondary | Pain intensity (NRS) | Eleven stepped numeric rating scale (NRS) for average pain last seven days. Higher values indicate higher pain intensity. | Change from baseline pain intensity (NRS) at 6 months | |
| Secondary | Pain Disability Index (PDI) | Quantifying pain related disability. Range 0-70 where a higher value indicates more disability. | Change from baseline disability (PDI) at 6 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
| Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
| Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
| Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
| Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
| Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
| Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
| Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
| Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
| Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
| Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
| Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
| Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
| Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
| Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
| Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
| Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
| Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
| Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|